v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock
Limited common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2024   63,710,409 9,164,193      
Beginning balance at Dec. 31, 2024 $ 421,445 $ 637 $ 92 $ 946,037 $ (525,541) $ 220
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Unrealized loss on marketable securities $ (130)         (130)
Issuances of common stock upon stock option exercises (in shares) 48,198 48,198        
Issuances of common stock upon stock option exercises $ 423 $ 1   422    
Issuance of common stock upon vesting of RSUs and PRSUs (in shares)   420,395        
Issuance of common stock upon vesting of RSUs and PRSUs 0 $ 4   (4)    
Stock-based compensation 11,574     11,574    
Net loss (59,808)       (59,808)  
Ending balance (in shares) at Mar. 31, 2025   64,179,002 9,164,193      
Ending balance at Mar. 31, 2025 373,504 $ 642 $ 92 958,029 (585,349) 90
Beginning balance (in shares) at Dec. 31, 2025   64,515,380 9,164,193      
Beginning balance at Dec. 31, 2025 364,053 $ 645 $ 92 992,015 (628,806) 107
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Unrealized loss on marketable securities $ (135)         (135)
Issuances of common stock upon stock option exercises (in shares) 185,915 185,915        
Issuances of common stock upon stock option exercises $ 583     581    
Issuance of common stock upon vesting of RSUs and PRSUs (in shares)   682,015        
Issuance of common stock upon vesting of RSUs and PRSUs 0 $ 7   (7)    
Stock-based compensation 9,073     9,073    
Net loss (60,026)       (60,026)  
Ending balance (in shares) at Mar. 31, 2026   65,383,310 9,164,193      
Ending balance at Mar. 31, 2026 $ 313,548 $ 654 $ 92 $ 1,001,662 $ (688,832) $ (28)